CAR T cells plus ibrutinib in relapsed/refractory MCL; targeting SGF29 in AML; diffusion-limited oxygen release from stored blood
This episode covers CAR T cells and ibrutinib for mantle cell lymphoma, a new approach targeting SGF29 in acute myeloid leukemia, and research on diffusion-limited oxygen release from stored blood.